发明名称 DEVELOPMENT OF DIAGONSTIC AND PROGNOSTIC METHODS FOR CHRONIC MYELODAL LEUKEMIA BY MEASUREMENT OF EXPRESSION LEVELS OF BCR-ABL AND DRUG-RESISTANT BCR-ABL MUTANTS WITH QUANTITIATIVE MASS SPECTROMETRY
摘要 PURPOSE: A method for quantitative analysis of Bcr/Abl hybrid protein using a mass spectrometer is provided to ensure excellent analysis accuracy. CONSTITUTION: A composition for quantitative measurement of Bcr-Abl hybrid or Abl matant protein with gleevec tolerance contains a peptide of LGGGQHGEVYEGVWK(sequence 1) or PPFYIIIE(sequence number 7) as an active ingredient. The tytosine residue of the peptide is phosphorylated. Valine, isoleucine, lysine, or leucine in the peptide is substituted with isotope. A method for quantitation of Bcr-Abl hybrid or Abl mutant protein having gleevec resistance comprises: a step of isolating a target protein from a sample; a step of treating the protein with protease; and a step of performing mass spectrometry of the treated peptides.
申请公布号 KR20120089608(A) 申请公布日期 2012.08.13
申请号 KR20120044855 申请日期 2012.04.27
申请人 KONKUK UNIVERSITY INDUSTRIAL COOPERATION CORP. 发明人 KIM, KWANG PYO
分类号 G01N33/68;C12Q1/37 主分类号 G01N33/68
代理机构 代理人
主权项
地址